Research ArticleOriginal Article

Development and evaluation of the screening performance of a low-cost high-risk screening strategy for breast cancer

Yubei Huang, Huan Wang, Zhangyan Lyu, Hongji Dai, Peifang Liu, Ying Zhu, Fengju Song and Kexin Chen
Cancer Biology & Medicine September 2022, 19 (9) 1375-1384; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0758

References

  1. 1.↵
    2. Britt KL,
    3. Cuzick J,
    4. Phillips KA.
    Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020; 20: 417–36.
    OpenUrlCrossRef
  2. 2.↵
    2. Sung H,
    3. Ferlay J,
    4. Siegel RL,
    5. Laversanne M,
    6. Soerjomataram I,
    7. Jemal A, et al.
    Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71: 209–49.
    OpenUrlCrossRefPubMed
  3. 3.↵
    2. Bray F,
    3. Ferlay J,
    4. Soerjomataram I,
    5. Siegel RL,
    6. Torre LA,
    7. Jemal A.
    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394–424.
    OpenUrlCrossRefPubMed
  4. 4.↵
    2. Bai A,
    3. Li H,
    4. Huang Y,
    5. Liu X,
    6. Gao Y,
    7. Wang P, et al.
    A survey of overall life satisfaction and its association with breast diseases in Chinese women. Cancer Med. 2016; 5: 111–9.
    OpenUrl
  5. 5.↵
    2. Huang Y,
    3. Dai H,
    4. Song F,
    5. Li H,
    6. Yan Y,
    7. Yang Z, et al.
    Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women. Sci Rep. 2016; 6: 39459.
  6. 6.↵
    2. Gao Y,
    3. Huang Y,
    4. Song F,
    5. Dai H,
    6. Wang P,
    7. Li H, et al.
    Urban-rural disparity of overweight/obesity distribution and its potential trend with breast cancer among Chinese women. Oncotarget. 2016; 7: 56608–18.
    OpenUrl
  7. 7.
    2. Huang Y,
    3. Zhang X,
    4. Li W,
    5. Song F,
    6. Dai H,
    7. Wang J, et al.
    A meta-analysis of the association between induced abortion and breast cancer risk among Chinese females. Cancer Causes Control. 2014; 25: 227–36.
    OpenUrl
  8. 8.
    2. Chen C,
    3. Huang YB,
    4. Liu XO,
    5. Gao Y,
    6. Dai HJ,
    7. Song FJ, et al.
    Active and passive smoking with breast cancer risk for Chinese females: a systematic review and meta-analysis. Chin J Cancer. 2014; 33: 306–16.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.
    2. Liu XO,
    3. Huang YB,
    4. Gao Y,
    5. Chen C,
    6. Yan Y,
    7. Dai HJ, et al.
    Association between dietary factors and breast cancer risk among Chinese females: systematic review and meta-analysis. Asian Pac J Cancer Prev. 2014; 15: 1291–8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Dai H,
    3. Yan Y,
    4. Wang P,
    5. Liu P,
    6. Cao Y,
    7. Xiong L, et al.
    Distribution of mammographic density and its influential factors among Chinese women. Int J Epidemiol. 2014; 43: 1240–51.
    OpenUrlCrossRefPubMed
  11. 11.↵
    2. Gao Y,
    3. Huang YB,
    4. Liu XO,
    5. Chen C,
    6. Dai HJ,
    7. Song FJ, et al.
    Tea consumption, alcohol drinking and physical activity associations with breast cancer risk among Chinese females: a systematic review and meta-analysis. Asian Pac J Cancer Prev. 2013; 14: 7543–50.
    OpenUrl
  12. 12.↵
    2. Myers ER,
    3. Moorman P,
    4. Gierisch JM,
    5. Havrilesky LJ,
    6. Grimm LJ,
    7. Ghate S, et al.
    Benefits and harms of breast cancer screening: a systematic review. J Am Med Assoc. 2015; 314: 1615–34.
    OpenUrlCrossRefPubMed
  13. 13.↵
    Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012; 380: 1778–86.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    2. Fan L,
    3. Strasser-Weippl K,
    4. Li J,
    5. St Louis J,
    6. Finkelstein DM,
    7. Yu K, et al.
    Breast cancer in China. Lancet Oncol. 2014; 15: e279–89.
    OpenUrlCrossRefPubMed
  15. 15.↵
    2. Bevers TB,
    3. Helvie M,
    4. Bonaccio E,
    5. Calhoun KE,
    6. Daly MB,
    7. Farrar WB, et al.
    Breast cancer screening and diagnosis, version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018; 16: 1362–89.
    OpenUrlAbstract/FREE Full Text
  16. 16.
    2. Monticciolo DL,
    3. Newell MS,
    4. Moy L,
    5. Niell B,
    6. Monsees B,
    7. Sickles EA.
    Breast cancer screening in women at higher-than-average risk: recommendations from the ACR. J Am Coll Radiol. 2018; 15: 408–14.
    OpenUrlCrossRef
  17. 17.
    2. Oeffinger KC,
    3. Fontham ET,
    4. Etzioni R,
    5. Herzig A,
    6. Michaelson JS,
    7. Shih YC, et al.
    Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. J Am Med Assoc. 2015; 314: 1599–14.
    OpenUrlCrossRefPubMed
  18. 18.↵
    2. Saslow D,
    3. Boetes C,
    4. Burke W,
    5. Harms S,
    6. Leach MO,
    7. Lehman CD, et al.
    American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007; 57: 75–89.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    2. Shen S,
    3. Zhou Y,
    4. Xu Y,
    5. Zhang B,
    6. Duan X,
    7. Huang R, et al.
    A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer. 2015; 112: 998–1004.
    OpenUrlPubMed
  20. 20.↵
    2. Berg WA,
    3. Bandos AI,
    4. Mendelson EB,
    5. Lehrer D,
    6. Jong RA,
    7. Pisano ED.
    Ultrasound as the primary screening test for breast cancer: analysis from ACRIN 6666. J Natl Cancer Inst. 2016; 108: djv367.
  21. 21.
    2. Yang L,
    3. Wang S,
    4. Huang Y.
    An exploration for quantification of overdiagnosis and its effect for breast cancer screening. Chin J Cancer Res. 2020; 32: 26–35.
    OpenUrl
  22. 22.↵
    2. Yang L,
    3. Wang S,
    4. Zhang L,
    5. Sheng C,
    6. Song F,
    7. Wang P, et al.
    Performance of ultrasonography screening for breast cancer: a systematic review and meta-analysis. BMC Cancer. 2020; 20: 499.
    OpenUrl
  23. 23.↵
    2. Dong H,
    3. Huang Y,
    4. Song F,
    5. Dai H,
    6. Liu P,
    7. Zhu Y, et al.
    Improved performance of adjunctive ultrasonography after mammography screening for breast cancer among Chinese females. Clin Breast Cancer. 2018; 18: e353–61.
    OpenUrl
  24. 24.↵
    2. Chlebowski RT,
    3. Anderson GL,
    4. Lane DS,
    5. Aragaki AK,
    6. Rohan T,
    7. Yasmeen S, et al.
    Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst. 2007; 99: 1695–705.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    2. Chen J,
    3. Pee D,
    4. Ayyagari R,
    5. Graubard B,
    6. Schairer C,
    7. Byrne C, et al.
    Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006; 98: 1215–26.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    2. Rosner B,
    3. Colditz GA.
    Nurses’ health study: log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst. 1996; 88: 359–64.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.
    2. Gail MH,
    3. Brinton LA,
    4. Byar DP,
    5. Corle DK,
    6. Green SB,
    7. Schairer C, et al.
    Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989; 81: 1879–86.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    2. Zheng W,
    3. Wen W,
    4. Gao YT,
    5. Shyr Y,
    6. Zheng Y,
    7. Long J, et al.
    Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst. 2010; 102: 972–81.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    2. Wang X,
    3. Huang Y,
    4. Li L,
    5. Dai H,
    6. Song F,
    7. Chen K.
    Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis. Breast Cancer Res. 2018; 20: 18.
    OpenUrlPubMed
  30. 30.↵
    2. Yadav S,
    3. Hartkop S,
    4. Cardenas PY,
    5. Ladkany R,
    6. Halalau A,
    7. Shoichet S, et al.
    Utilization of a breast cancer risk assessment tool by internal medicine residents in a primary care clinic: impact of an educational program. BMC Cancer. 2019; 19: 228.
    OpenUrl
  31. 31.↵
    2. Corbelli J,
    3. Borrero S,
    4. Bonnema R,
    5. McNamara M,
    6. Kraemer K,
    7. Rubio D, et al.
    Use of the Gail model and breast cancer preventive therapy among three primary care specialties. J Womens Health (Larchmt). 2014; 23: 746–52.
    OpenUrlPubMed
  32. 32.↵
    2. Xu YL,
    3. Sun Q,
    4. Shan GL,
    5. Zhang J,
    6. Liao HB,
    7. Li SY, et al.
    A case-control study on risk factors of breast cancer in China. Arch Med Sci. 2012; 8: 303–9.
    OpenUrlPubMed
  33. 33.
    2. Li W,
    3. Ray RM,
    4. Lampe JW,
    5. Lin MG,
    6. Gao DL,
    7. Wu C, et al.
    Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. Int J Cancer. 2005; 115: 981–93.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    2. Yuan JM,
    3. Yu MC,
    4. Ross RK,
    5. Gao YT,
    6. Henderson BE.
    Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res. 1988; 48: 1949–53.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    2. Wong IO,
    3. Kuntz KM,
    4. Cowling BJ,
    5. Lam CL,
    6. Leung GM.
    Cost effectiveness of mammography screening for Chinese women. Cancer. 2007; 110: 885–95.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    2. Chen W,
    3. Zheng R,
    4. Zuo T,
    5. Zeng H,
    6. Zhang S,
    7. He J.
    National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016; 28: 1–11.
    OpenUrlPubMed
  37. 37.↵
    2. Huang Z,
    3. Wen W,
    4. Zheng Y,
    5. Gao YT,
    6. Wu C,
    7. Bao P, et al.
    Breast cancer incidence and mortality: trends over 40 years among women in Shanghai, China. Ann Oncol. 2016; 27: 1129–34.
    OpenUrlCrossRefPubMed
  38. 38.↵
    2. Tice JA,
    3. Cummings SR,
    4. Smith-Bindman R,
    5. Ichikawa L,
    6. Barlow WE,
    7. Kerlikowske K.
    Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med. 2008; 148: 337–47.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    2. Gail MH,
    3. Costantino JP,
    4. Pee D,
    5. Bondy M,
    6. Newman L,
    7. Selvan M, et al.
    Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007; 99: 1782–92.
    OpenUrlCrossRefPubMedWeb of Science
  40. 40.
    2. Barlow WE,
    3. White E,
    4. Ballard-Barbash R,
    5. Vacek PM,
    6. Titus-Ernstoff L,
    7. Carney PA, et al.
    Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer Inst. 2006; 98: 1204–14.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.
    2. Lee CP,
    3. Irwanto A,
    4. Salim A,
    5. Yuan JM,
    6. Liu J,
    7. Koh WP, et al.
    Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population. Breast Cancer Res. 2014; 16: R64.
    OpenUrl
  42. 42.
    2. Darabi H,
    3. Czene K,
    4. Zhao W,
    5. Liu J,
    6. Hall P,
    7. Humphreys K.
    Breast cancer risk prediction and individualised screening based on common genetic variation and breast density measurement. Breast Cancer Res. 2012; 14: R25.
    OpenUrlCrossRefPubMed
  43. 43.
    2. Anothaisintawee T,
    3. Teerawattananon Y,
    4. Wiratkapun C,
    5. Kasamesup V,
    6. Thakkinstian A.
    Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Res Treat. 2012; 133: 1–10.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    2. Meads C,
    3. Ahmed I,
    4. Riley RD.
    A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance. Breast Cancer Res Treat. 2012; 132: 365–77.
    OpenUrlCrossRefPubMed
  45. 45.↵
    2. Gail MH,
    3. Benichou J.
    Validation studies on a model for breast cancer risk. J Natl Cancer Inst. 1994; 86: 573–5.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.
    2. Costantino JP,
    3. Gail MH,
    4. Pee D,
    5. Anderson S,
    6. Redmond CK,
    7. Benichou J, et al.
    Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999; 91: 1541–8.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.
    2. Mealiffe ME,
    3. Stokowski RP,
    4. Rhees BK,
    5. Prentice RL,
    6. Pettinger M,
    7. Hinds DA.
    Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. J Natl Cancer Inst. 2010; 102: 1618–27.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.
    2. Chay WY,
    3. Ong WS,
    4. Tan PH,
    5. Jie LN,
    6. Ho GH,
    7. Wong CS, et al.
    Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res. 2012; 14: R19.
    OpenUrlPubMed
  49. 49.↵
    2. Gao F,
    3. Machin D,
    4. Chow KY,
    5. Sim YF,
    6. Duffy SW,
    7. Matchar DB, et al.
    Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study). BMC Cancer. 2012; 12: 529.
    OpenUrlPubMed
  50. 50.↵
    2. Lauby-Secretan B,
    3. Scoccianti C,
    4. Loomis D,
    5. Benbrahim-Tallaa L,
    6. Bouvard V,
    7. Bianchini F, et al.
    Breast-cancer screening – viewpoint of the IARC Working Group. N Engl J Med. 2015; 372: 2353–8.
    OpenUrlCrossRefPubMed
  51. 51.↵
    2. Stomper PC,
    3. D’Souza DJ,
    4. DiNitto PA,
    5. Arredondo MA.
    Analysis of parenchymal density on mammograms in 1353 women 25–79 years old. AJR Am J Roentgenol. 1996; 167: 1261–5.
    OpenUrlCrossRefPubMedWeb of Science
  52. 52.↵
    2. Checka CM,
    3. Chun JE,
    4. Schnabel FR,
    5. Lee J,
    6. Toth H.
    The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol. 2012; 198: W292–5.
    OpenUrlCrossRefPubMedWeb of Science
  53. 53.↵
    2. Zhang S,
    3. Sun K,
    4. Zheng R,
    5. Zeng H,
    6. Wang S,
    7. Chen R, et al.
    Cancer incidence and mortality in China, 2015. JNCC. 2021; 1: 2–11.
    OpenUrl
  54. 54.↵
    2. Wang Q,
    3. Li J,
    4. Zheng S,
    5. Li J,
    6. Pang Y,
    7. Huang R, et al.
    Breast cancer stage at diagnosis and area-based socioeconomic status: a multicenter 10-year retrospective clinical epidemiological study in China. BMC Cancer. 2012; 12: 122.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords